Chrissy Teigen revealed she is 52 days sober again after having recently relapsed into alcoholism and assured the public that ...
Indian scientist highlights the absurdity of Silicon Valley techies working 60-hour weeks, relying on nannies and robots for ...
LOS ANGELES, CA – YouTuber-turned-TV star Lilly Singh now has a new title to flaunt: PhD. On October 15, her alma mater, York University, awarded her an honorary doctor of laws degree, recognizing her ...
If you’re like us, you’ve probably wondered what everyday stuff famous people add to their carts — like hair spray or an electric toothbrush. We asked actress, writer, and gender equality advocate ...
This is read by an automated voice. Please report any issues or inconsistencies here. Evangeline Lilly says much of her brain is “functioning at a decreased capacity” after her traumatic brain injury ...
In 2025, Lost and Marvel actor Evangeline Lilly suffered a concussion in May 2025 after fainting on the beach and hitting her head on the rock. To kick off 2026, the actor shared that the traumatic ...
Eli Lilly has shown patients maintained most of their weight loss after switching from injectable GLP-1s to its oral drug candidate, teeing the drugmaker up to target people taking Novo Nordisk’s ...
Eli Lilly will not seek a broad FDA approval for a combination of the company’s oral SERD med Inluriyo and CDK4/6 inhibitor Verzenio despite seemingly promising phase 3 results. Instead, the ...
Eli Lilly has surpassed analysts’ highest hopes for the efficacy of retatrutide, linking the triple agonist to 28.7% weight loss and a 75.8% reduction in pain scores in patients with obesity and knee ...
Eli Lilly has unveiled the location of the third of its four large-scale manufacturing facilities that it plans to build in the U.S. The drugmaker has selected Huntsville, Alabama, as the site of a $6 ...
Eli Lilly & Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up with rival Novo Nordisk A/S. Starting Monday, the lowest dose vial will cost ...
Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, in the past six months, driven not only by outstanding earnings and a notable margin increase, but also by reaching a $1T market cap and excitement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results